Research Article
Effect of Dexamethasone Implant on Subfoveal Choroidal Thickness in Early Period in Vitrectomized Eyes with Diabetic Macular Edema
Table 3
Change in subfoveal choroidal thickness of the groups.
| | | Group 1 (with DME) | Group 2 (without DME) | value | | Mean ± SD/n−% | Median | Mean ± SD/n−% | Median |
| | SFCT (μm) | | Preinjection | 205.8 ± 8.2 | 207.0 | 295.0 ± 4.6 | 294.0 | 0.000 | m | | Postinjection 1st month | 193.8 ± 7.2 | 195.0 | 292.3 ± 4.9 | 293.0 | 0.000 | m | | Postinjection 2nd month | 191.3 ± 6.3 | 193.0 | 295.4 ± 4.1 | 295.0 | 0.000 | m | | Postinjection 4th month | 187.4 ± 6.6 | 190.5 | 297.7 ± 4.5 | 296.0 | 0.000 | m |
|
|
mMann–Whitney U test; SFCT, subfoveal choroidal thickness; SD, standard deviation; μm, micrometer; DME, diabetic macular edema.
|
